Regulation of RUNX1 Expression and Activity
|
|
|
- AGO1
- AGO2
- AGO3
- AGO4
- AML1
- BCL1
- CAGH26
- CBFA2
- CBFB
- CCND1
- CCND2
- CCND3
- CDK6
- CDKN6
- EIF2C1
- EIF2C2
- EIF2C3
- EIF2C4
- KIAA1093
- KIAA1460
- KIAA1567
- KIAA1582
- KIAA1631
- MOV10
- MYL
- PML
- PP8675
- PRAD1
- PTP2C
- PTPN11
- RNF71
- RUNX1
- SHPTP2
- SRC
- SRC1
- TNRC6
- TNRC6A
- TNRC6B
- TNRC6C
- TRIM19
|
|
Inhibition of membrane repair
|
|
|
|
|
Formation of lateral plate mesoderm
|
|
|
- BMP2B
- BMP4
- DVR4
- FKHL5
- FOXF1
- FREAC1
- GATA4
- IHH
- SHH
|
|
Establishment of Sister Chromatid Cohesion
|
|
|
- APRIN
- AS3
- BAM
- BMH
- CDCA5
- CSPG6
- DXS423E
- EFO1
- ESCO1
- ESCO2
- FOE
- HR21
- KIAA0078
- KIAA0178
- KIAA0261
- KIAA0648
- KIAA0979
- KIAA1911
- NXP1
- PDS5
- PDS5A
- PDS5B
- RAD21
- SA1
- SA2
- SB1.8
- SCC1
- SCC3
- SMC1
- SMC1A
- SMC1L1
- SMC3
- SMC3L1
- STAG1
- STAG2
- WAPAL
- WAPL
|
|
Opioid Signalling
|
|
|
|
|
LXRs regulate gene expression to limit cholesterol uptake
|
|
|
- BZF1
- IDOL
- LXRA
- LXRB
- MYLIP
- NER
- NR1H2
- NR1H3
- NR2B1
- NR2B2
- RXRA
- RXRB
- UNR
|
|
MET activates RAP1 and RAC1
|
|
|
- CRK
- CRKL
- DOCK7
- GAB1
- GRF2
- HGF
- HPTA
- KIAA1771
- KREV1
- MET
- RAC1
- RAP1A
- RAP1B
- RAPGEF1
- TC25
|
|
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
|
|
|
- ANAPC1
- ANAPC10
- ANAPC11
- ANAPC12
- ANAPC15
- ANAPC16
- ANAPC2
- ANAPC3
- ANAPC4
- ANAPC5
- ANAPC6
- ANAPC7
- ANAPC8
- APC10
- APC2
- APC4
- APC5
- APC7
- C10orf104
- C11orf51
- C9orf17
- CDC14A
- CDC16
- CDC20
- CDC23
- CDC26
- CDC27
- CDH1
- CENP-27
- D0S1430E
- D17S978E
- E2EPF
- FYR
- FZR
- FZR1
- KIAA1242
- KIAA1406
- SFT
- TSG24
- UBC5A
- UBCH10
- UBCH5
- UBCH5A
- UBCH6
- UBE2C
- UBE2D1
- UBE2E1
- UBE2S
|
|
DCC mediated attractive signaling
|
|
|
- ABLIM
- ABLIM1
- ABLIM2
- ABLIM3
- CDC42
- DCC
- DOCK1
- FAK
- FAK1
- IGDCC1
- KIAA0059
- KIAA0843
- KIAA1808
- LIMAB1
- NCK
- NCK1
- NTN1
- NTN1L
- PTK2
- RAC1
- SRC
- SRC1
- TC25
- TRIO
- WASL
|
|
MET Receptor Activation
|
|
|
- HAI1
- HAI2
- HGF
- HGFAC
- HPN
- HPTA
- KOP
- MET
- SPINT1
- SPINT2
- TMPRSS1
|
|
Glutathione conjugation
|
|
|
- AKR1A1
- ALDR1
- ALR
- ESD
- FAEES3
- GST1
- GST12
- GST2
- GST3
- GST4
- GST5
- GSTA1
- GSTA2
- GSTA3
- GSTA4
- GSTA5
- GSTK1
- GSTM1
- GSTM2
- GSTM3
- GSTM4
- GSTM5
- GSTO1
- GSTO2
- GSTP1
- GSTS
- GSTT1
- GSTT2
- GSTT2B
- GSTTLP28
- GSTZ1
- HPGDS
- MAAI
- MGST
- MGST1
- MGST2
- MGST3
- PGDS
- PTGDS2
|
|
NFE2L2 regulating TCA cycle genes
|
|
|
- IDH1
- ME1
- NFE2L2
- NRF2
- PICD
|
|
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
|
|
|
- FARP2
- FES
- FPS
- FYN
- KIAA0463
- KIAA0589
- KIAA0793
- KIAA1027
- KIAA1550
- NOV
- NRP
- NRP1
- OCT
- PIP5K1C
- PLEKHC3
- PLXN1
- PLXN2
- PLXN4
- PLXNA1
- PLXNA2
- PLXNA3
- PLXNA4
- PLXNA4A
- PLXNA4B
- RAC1
- RHO6
- RND1
- RRAS
- SEMA3A
- SEMAD
- SEX
- TC25
- TLN
- TLN1
- VEGF165R
|
|
Variant SLC6A14 may confer susceptibility towards obesity
|
|
|
|
|
Integrin cell surface interactions
|
|
|
- AGRIN
- AGRN
- BNSP
- BSG
- C21orf43
- CD11A
- CD11B
- CD11C
- CD18
- CD44
- CD47
- CD49B
- CD49D
- CDH1
- CDHE
- COL13A1
- COL16A1
- COL18A1
- COL23A1
- COL4A1
- COL4A2
- COL4A3
- COL4A4
- COL9A1
- COL9A2
- COL9A3
- COMP
- CR3A
- F11R
- FBN
- FBN1
- FGA
- FGB
- FGG
- FLK1
- FN
- FN1
- FNRA
- FNRB
- GP2B
- GP3A
- HSPG2
- HXB
- IBSP
- ICAM1
- ICAM2
- ICAM3
- ICAM4
- ICAM5
- ITGA1
- ITGA10
- ITGA11
- ITGA2
- ITGA2B
- ITGA3
- ITGA4
- ITGA5
- ITGA6
- ITGA7
- ITGA8
- ITGA9
- ITGAB
- ITGAD
- ITGAE
- ITGAL
- ITGAM
- ITGAV
- ITGAX
- ITGB1
- ITGB2
- ITGB3
- ITGB5
- ITGB6
- ITGB7
- ITGB8
- JAM1
- JAM2
- JAM3
- JCAM
- KDR
- LDC
- LHR
- LUM
- LW
- MDF2
- MDU2
- MDU3
- MER6
- MFI7
- MIC4
- MSK12
- MSK18
- MSK8
- OPN
- PECAM1
- SLRR2D
- SPP1
- THBS1
- TLCN
- TLN
- TNC
- TSP
- TSP1
- UVO
- VCAM1
- VEGFR2
- VEJAM
- VNRA
- VTN
- VTNR
|
|
Azathioprine ADME
|
|
|
- ABCC4
- ABCC5
- CNT2
- CNT3
- DER12
- ENT1
- ENT2
- GMK
- GMPK
- GMPS
- GST1
- GST2
- GSTA1
- GSTA2
- GSTM1
- GUK1
- HNP36
- HPRT
- HPRT1
- IMPD1
- IMPD2
- IMPDH1
- IMPDH2
- MOATB
- MRP4
- MRP5
- MTH2
- NDPKA
- NM23
- NM23B
- NME1
- NME2
- NUDT15
- RAC1
- SLC28A2
- SLC28A3
- SLC29A1
- SLC29A2
- TC25
- TPMT
- VAV
- VAV1
- VAV2
- VAV3
- XDH
- XDHA
|
|
Signaling by BMP
|
|
|
- ACVR2
- ACVR2A
- ACVR2B
- ACVRL1
- ACVRLK1
- ACVRLK3
- ALK1
- ALK3
- AMH
- AMHR
- AMHR2
- BMP10
- BMP2
- BMP2A
- BMP9
- BMPR1A
- BMPR1B
- BMPR2
- BSP1
- CER1
- CHRDL1
- CKTSF1B2
- DAND3
- DAND4
- DPC4
- FRP
- FSTL1
- GDF2
- GREM2
- INHA
- INHBA
- KIAA0305
- KIAA1625
- MADH1
- MADH4
- MADH5
- MADH6
- MADH7
- MADH8
- MADH9
- MADR1
- MIF
- MISR2
- NOG
- NRLN1
- PPH1
- PRDC
- SFT
- SKI
- SMAD1
- SMAD4
- SMAD5
- SMAD6
- SMAD7
- SMAD8
- SMAD9
- SMURF1
- SMURF2
- TGFBR3
- UBC5A
- UBC5C
- UBCH5
- UBCH5A
- UBCH5C
- UBE2D1
- UBE2D3
- ZFYVE16
|
|
Scavenging by Class B Receptors
|
|
|
- APOA1
- APOB
- CD36
- GP3B
- GP4
- SAA1
- SSC5D
|
|
Glycerophospholipid catabolism
|
|
|
- C9orf111
- ENPP6
- GDE1
- GDE2
- GDE4
- GDE7
- GDPD1
- GDPD3
- GDPD5
- MIR16
- NTE
- PNPLA6
- PNPLA7
|
|
Creatine metabolism
|
|
|
- AGAT
- BGT1
- CKB
- CKBB
- CKM
- CKMM
- CKMT
- CKMT1A
- CKMT1B
- CKMT2
- GABT3
- GAMT
- GAT3
- GATM
- PROT
- SLC6A11
- SLC6A12
- SLC6A7
- SLC6A8
|
|
SMAD4 MH2 Domain Mutants in Cancer
|
|
|
- DPC4
- MADH2
- MADH3
- MADH4
- MADR2
- SMAD2
- SMAD3
- SMAD4
|
|
Impaired BRCA2 translocation to the nucleus
|
|
|
- BRCA2
- C7orf76
- DSS1
- FACD
- FANCD1
- SEM1
- SHFDG1
- SHFM1
|
|
LXRs regulate gene expression linked to gluconeogenesis
|
|
|
- LXRA
- NR1H3
- NR2B1
- NR2B2
- NRIP1
- PCK1
- PEPCK1
- RXRA
- RXRB
|
|
Defective gamma-carboxylation of F9
|
|
|
|
|
Enzymatic degradation of dopamine by COMT
|
|
|
- COMT
- COMT2
- LRTOMT
- MAOA
- TOMT
|
|